skip to Main Content

Pomezia, Rome, is working on a vaccine

Corriere della Sera

IRBM (who developed the vaccine against Ebola) is collaborating with Oxford. «We are purifying the molecule and we are going to produce the first 1000 doses within a week»

Vaccine for the novel coronavirus could arrive from the same Italian research institute that developed the vaccine against Ebola in 2014 and a drug for AIDS, named Isentress. IRBM, located in Pomezia, Rome, is now working on a coronavirus vaccine with promising results. Mr. Pietro Di Lorenzo, President and CEO of IRBM, says: «The vaccine could be ready by the summer. We are going to begin with trial on mice and then we will start on human » Also Moderna from USA as well as many Israelian companies are working towards the same goal. Pietro Di Lorenzo emphasizes: «In this race everyone is going to win. We will be all useful to eradicate the virus», then he says: «We are collaborating with an expert in coronavirus, the Oxford University, which already developed the vaccine for MERS […] We are manufacturing the first 1000 doses of the vaccine by a week».

Article by Flavia Fiorentino published on Corriere Roma09/03/2020

Download pdf
Back To Top